XML 25 R8.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Cash flows from operating activities:    
Net income $ 115,564 $ 216,222
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 159,205 159,448
Non-cash compensation expense 10,802 10,069
Income from unconsolidated joint ventures (3,084) (1,791)
Distributions of net cash flow from operations of unconsolidated joint ventures 1,861 10,718
Gains from investments in securities (1,042) (259)
Non-cash portion of interest expense (7,729) (10,138)
Gains on sales of real estate (133) (67,623)
Change in assets and liabilities:    
Cash held in escrows 6,664 1,940
Tenant and other receivables, net 19,023 25,018
Accrued rental income, net (9,158) (12,981)
Prepaid expenses and other assets (21,197) 45,560
Accounts payable and accrued expenses (16,306) (5,209)
Accrued interest payable 22,781 31,192
Other liabilities (7,090) (33,319)
Tenant leasing costs (23,631) (19,867)
Total adjustments 130,966 132,758
Net cash provided by operating activities 246,530 348,980
Cash flows from investing activities:    
Construction in progress (154,518) (122,940)
Building and other capital improvements (43,687) (25,329)
Tenant improvements (50,810) (55,739)
Proceeds from sales of real estate 133 104,816
Proceeds from sales of real estate placed in escrow 0 (104,696)
Proceeds from sales of real estate released from escrow 0 104,696
Cash released from escrow for investing activities 5,230 0
Cash released from escrow for land sale contracts 0 488
Capital contributions to unconsolidated joint ventures (17,980) (10,215)
Investments in securities, net (961) (438)
Net cash used in investing activities (262,593) (109,357)
Cash flows from financing activities:    
Repayments of mortgage notes payable (5,038) (6,265)
Proceeds from unsecured senior notes 0 997,080
Borrowings on unsecured line of credit 175,000 0
Repayments of unsecured line of credit (70,000) 0
Payments on real estate financing transactions (480) (781)
Deferred financing costs 0 (8,047)
Net proceeds from equity transactions (183) (657)
Dividends and distributions (131,555) (328,567)
Contributions from noncontrolling interests in property partnerships 8,145 2,489
Distributions to noncontrolling interests in property partnerships (13,801) (12,915)
Net cash provided by (used in) financing activities (37,912) 642,337
Net increase (decrease) in cash and cash equivalents (53,975) 881,960
Cash and cash equivalents, beginning of period 356,914 723,718
Cash and cash equivalents, end of period 302,939 1,605,678
Supplemental disclosures:    
Cash paid for interest 92,774 93,524
Interest capitalized 12,345 9,269
Non-cash investing and financing activities:    
Write off of fully depreciated real estate (49,292) (17,518)
Additions to real estate included in accounts payable and accrued expenses 44,708 (24,857)
Dividends and distributions declared but not paid 130,418 113,079
Conversions of noncontrolling interests to stockholders’ equity 793 446
Issuance of restricted securities to employees 34,592 32,630
Boston Properties Limited Partnership    
Cash flows from operating activities:    
Net income 117,711 220,378
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 157,058 157,461
Non-cash compensation expense 10,802 10,069
Income from unconsolidated joint ventures (3,084) (1,791)
Distributions of net cash flow from operations of unconsolidated joint ventures 1,861 10,718
Gains from investments in securities (1,042) (259)
Non-cash portion of interest expense (7,729) (10,138)
Gains on sales of real estate (133) (69,792)
Change in assets and liabilities:    
Cash held in escrows 6,664 1,940
Tenant and other receivables, net 19,023 25,018
Accrued rental income, net (9,158) (12,981)
Prepaid expenses and other assets (21,197) 45,560
Accounts payable and accrued expenses (16,306) (5,209)
Accrued interest payable 22,781 31,192
Other liabilities (7,090) (33,319)
Tenant leasing costs (23,631) (19,867)
Total adjustments 128,819 128,602
Net cash provided by operating activities 246,530 348,980
Cash flows from investing activities:    
Construction in progress (154,518) (122,940)
Building and other capital improvements (43,687) (25,329)
Tenant improvements (50,810) (55,739)
Proceeds from sales of real estate 133 104,816
Proceeds from sales of real estate placed in escrow 0 (104,696)
Proceeds from sales of real estate released from escrow 0 104,696
Cash released from escrow for investing activities 5,230 0
Cash released from escrow for land sale contracts 0 488
Capital contributions to unconsolidated joint ventures (17,980) (10,215)
Investments in securities, net (961) (438)
Net cash used in investing activities (262,593) (109,357)
Cash flows from financing activities:    
Repayments of mortgage notes payable (5,038) (6,265)
Proceeds from unsecured senior notes 0 997,080
Borrowings on unsecured line of credit 175,000 0
Repayments of unsecured line of credit (70,000) 0
Payments on real estate financing transactions (480) (781)
Deferred financing costs 0 (8,047)
Net proceeds from equity transactions (183) (657)
Dividends and distributions (131,555) (328,567)
Contributions from noncontrolling interests in property partnerships 8,145 2,489
Distributions to noncontrolling interests in property partnerships (13,801) (12,915)
Net cash provided by (used in) financing activities (37,912) 642,337
Net increase (decrease) in cash and cash equivalents (53,975) 881,960
Cash and cash equivalents, beginning of period 356,914 723,718
Cash and cash equivalents, end of period 302,939 1,605,678
Supplemental disclosures:    
Cash paid for interest 92,774 93,524
Interest capitalized 12,345 9,269
Non-cash investing and financing activities:    
Write off of fully depreciated real estate (49,292) (17,518)
Additions to real estate included in accounts payable and accrued expenses 44,708 (24,857)
Dividends and distributions declared but not paid 130,418 113,079
Conversions of noncontrolling interests to stockholders’ equity 793 446
Issuance of restricted securities to employees $ 34,592 $ 32,630